SCHEMBL6169212

SCHEMBL6169212

CCN1CCN(CCC(=O)O)C(=O)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ GAA P10253 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ SIRT1 Q96EB6 1/20 0.42
▸ S1PR1 P21453 1/20 0.42
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ INMT O95050 2/20 0.37
▸ APEX1 P27695 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ FFAR3 O14843 1/20 0.34
▸ HDAC3 O15379 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3492650 0.80 GAA (0.54) ALDH1A1GAAL3MBTL1KDM4EPOLB
SCHEMBL12566554 0.78 GAA (0.48) ALDH1A1GAAL3MBTL1KDM4EALOX15
SCHEMBL9328091 0.74 GAA (0.45) GAAL3MBTL1KDM4EALOX15POLB
SCHEMBL10964562 0.74 GAA (0.40) GAAL3MBTL1ALOX15POLBSMN1; SMN2
SCHEMBL12208453 0.73 GAA (0.42) GAAL3MBTL1ALOX15POLBINMT
SCHEMBL7148826 0.73 GAA (0.46) GAAL3MBTL1KDM4EALOX15POLB
SCHEMBL13621180 0.72 KDM4E (0.41) ALDH1A1PKMGAAL3MBTL1KDM4E
SCHEMBL11227178 0.71 KDM4E (0.44) ALDH1A1PKMGAAL3MBTL1KDM4E
SCHEMBL6468845 0.71 GAA (0.45) GAAL3MBTL1KDM4EPOLBMEN1
SCHEMBL11225104 0.70 GAA (0.42) GAAL3MBTL1KDM4EPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1495020-A1 N-(MORPHOLIN-2YL) METHYL ACETAMIDE DERIVATIVES AS CCR-3 ANTAGONISTS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2005-01-12 — — EP disclosed
WO-2003082863-A1 N-(MORPHOLIN-2YL) METHYL ACETAMIDE DERIVATIVES AS CCR-3 ANTAGONISTS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2003-10-09 — — WO disclosed
Send feedback